A controversial stem cell treatment may have another shot at a clinical trial funded by the Italian government after a ruling last week from a regional administrative court. The ruling suspends the September decision of a federal scientific committee to not finance the trial. The committee concluded that the treatment, which uses bone marrow stem cells purported to treat neurodegenerative diseases, has no scientific foundation.
展开▼
